JP2025506186A5 - - Google Patents
Info
- Publication number
- JP2025506186A5 JP2025506186A5 JP2024547694A JP2024547694A JP2025506186A5 JP 2025506186 A5 JP2025506186 A5 JP 2025506186A5 JP 2024547694 A JP2024547694 A JP 2024547694A JP 2024547694 A JP2024547694 A JP 2024547694A JP 2025506186 A5 JP2025506186 A5 JP 2025506186A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- hydrogen
- substituted
- unsubstituted
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263309337P | 2022-02-11 | 2022-02-11 | |
| US63/309,337 | 2022-02-11 | ||
| US202263327342P | 2022-04-04 | 2022-04-04 | |
| US63/327,342 | 2022-04-04 | ||
| US202263335150P | 2022-04-26 | 2022-04-26 | |
| US63/335,150 | 2022-04-26 | ||
| US202263352809P | 2022-06-16 | 2022-06-16 | |
| US63/352,809 | 2022-06-16 | ||
| PCT/US2023/062436 WO2023154896A2 (en) | 2022-02-11 | 2023-02-10 | Trkb ligand conjugated compounds and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025506186A JP2025506186A (ja) | 2025-03-07 |
| JP2025506186A5 true JP2025506186A5 (cg-RX-API-DMAC10.html) | 2026-02-18 |
Family
ID=87565161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024547694A Pending JP2025506186A (ja) | 2022-02-11 | 2023-02-10 | Trkbリガンドコンジュゲート化合物及びその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250161459A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4475837A2 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2025506186A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20240159828A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2023218398A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3251455A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL314847A (cg-RX-API-DMAC10.html) |
| MX (1) | MX2024009892A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023154896A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4698652A2 (en) * | 2023-04-20 | 2026-02-25 | Adarx Pharmaceuticals, Inc. | Mapt-modulating compositions and methods of use thereof |
| WO2025038971A1 (en) * | 2023-08-17 | 2025-02-20 | Adarx Pharmaceuticals, Inc. | Oligonucleotides containing a ligand at a nucleobase, 2' position, or 3' position |
| AU2025211114A1 (en) * | 2024-01-24 | 2026-06-18 | F. Hoffmann-La Roche Ag | Linkers for site-specific protein conjugation |
| WO2026057077A1 (zh) * | 2024-09-14 | 2026-03-19 | 厦门甘宝利生物医药有限公司 | 一种多靶点rna抑制剂 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0381902A1 (en) * | 1989-01-09 | 1990-08-16 | Merrell Dow Pharmaceuticals Inc. | Tetralin derivatives |
| US7166755B2 (en) * | 2004-09-30 | 2007-01-23 | Air Products And Chemicals, Inc. | Synthesis of pentafluorosulfanylnaphthalene |
-
2023
- 2023-02-10 US US18/837,377 patent/US20250161459A1/en active Pending
- 2023-02-10 JP JP2024547694A patent/JP2025506186A/ja active Pending
- 2023-02-10 EP EP23753724.6A patent/EP4475837A2/en active Pending
- 2023-02-10 KR KR1020247029980A patent/KR20240159828A/ko active Pending
- 2023-02-10 IL IL314847A patent/IL314847A/en unknown
- 2023-02-10 AU AU2023218398A patent/AU2023218398A1/en active Pending
- 2023-02-10 CA CA3251455A patent/CA3251455A1/en active Pending
- 2023-02-10 WO PCT/US2023/062436 patent/WO2023154896A2/en not_active Ceased
-
2024
- 2024-08-12 MX MX2024009892A patent/MX2024009892A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2728148B2 (ja) | アミノアルギニンの分離および身体内の酸化窒素生成を遮断するための用途 | |
| JPH08503940A (ja) | 酵素阻害薬 | |
| JP2003502339A (ja) | プリン誘導体 | |
| HRP20000904A2 (en) | Farnesyl protein transferase inhibitors for treating arthropathies | |
| JPH0629186B2 (ja) | 抗低酸素および虚血薬理組成物 | |
| JPH07509219A (ja) | H↓3受容体アンタゴニストとしての4−[4’−ピペリジニルまたは3’−ピロリジニル]置換イミダゾールおよび治療上のその使用方法 | |
| JPH02290841A (ja) | 新規化合物、その製法及びそれを含む医薬組成物 | |
| JPS636058B2 (cg-RX-API-DMAC10.html) | ||
| JP2000510129A (ja) | ジスタマイシン誘導体、その調製方法並びに抗腫瘍薬及び抗ウイルス薬としてのその使用 | |
| KR0130977B1 (ko) | 항종양제로서 폴리아민 유도체 | |
| RU2441875C2 (ru) | Терапевтические соединения | |
| HUT64553A (en) | A process for preparing anti-viral and anti-tumouric 2'-desoxi-2',2'-difluorine-(2,6,8-substituted)-purine-nucleosides and pharmaceutical compositions comprising them as active ingredient | |
| JPH09508382A (ja) | K−チャネル遮断薬用シアノグアニジン類 | |
| US20040092536A1 (en) | Neurologically active compounds and compounds with multiple activities | |
| WO2025153624A1 (en) | Imidazo[1,2-d][1,2,4]triazine derivatives for use as inhibitors of the nlrp3 inflammasome pathway | |
| JPH08512279A (ja) | 抗サイトメガロウイルス剤としてのポリアミン誘導体類 | |
| JP3773148B2 (ja) | 虚血性疾患予防、治療剤及び臓器保存剤 | |
| WO2023072292A1 (zh) | 一种高效抗病毒化合物及其用途 | |
| JP3025557B2 (ja) | 2‐アルキニルアデノシン誘導体 | |
| JP2000503986A (ja) | Hiv―1陽性であるヒトにおけるデラビルジンおよびプロテアーゼ・インヒビターの使用 | |
| DE69520876T2 (de) | Gamma-diketonverbindung mit thrombozytenaggregationshemmender wirkung | |
| JP3094450B2 (ja) | 神経保護特性を有するピペリジン誘導体 | |
| JP2815691B2 (ja) | Krn2391酸付加塩およびその用途 | |
| JPH03291261A (ja) | ω−アミノ−フェニルアルカノニトリル誘導体 | |
| JPH0859688A (ja) | 5’−チオノエステル置換トリフルオロチミジン誘導体およびそれを有効成分とする制癌剤 |